Latest Conference Articles

At the Horizons in Advanced Practice meeting, Omar Noor, MD, led NP and PA attendees through 3 complex cases of atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria.

Discover the latest trends in aesthetic medicine from ASDS 2025, focusing on safer treatments, improved skin quality, and innovative injectables.

Discover the latest advancements in dermatology from the 2025 Elevate-Derm Fall Conference held in Tampa, Florida.

At Elevate-Derm, Shanna Miranti, MPAS, PA-C, and Larissa Schmidt, DPM, outlined how interdisciplinary education, shared therapeutic advances, and evolving career pathways are strengthening the connection between dermatology and podiatry.

At Elevate-Derm 2025, Lisa Weiss, MMSc, PA-C, outlined the multifactorial approach to CHE, the clinical utility of delgocitinib, and her expanding educational and leadership priorities heading into 2026.

James Canner, PA-C, outlines key updates in acne therapeutics, alopecia management, and rheumatology–dermatology collaboration presented at Elevate-Derm Fall.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Explore the latest advancements and expert insights from ISDS 2025 held in New York, New York.

Massimo Gadina, PhD, underscored the need for genetics-guided patient selection to improve treatment specificity in inflammatory skin diseases.

At Elevate-Derm Fall, Ken Korber, PA-C, MHPE, DFAAPA, highlighted how literacy-aware communication and team-based collaboration can elevate patient understanding, adherence, and outcomes.

At Elevate-Derm Fall, Ted Rosen, MD, detailed how rapidly evolving resistance in bacteria, fungi, viruses, and more is reshaping therapeutic choices.

Dupilumab clears AD clinically and histologically, but deep immune profiling shows disease-memory T cells persist in the skin.

At Elevate-Derm 2025, Diego Ruiz Dasilva, MD, emphasized cross-role teamwork and urged clinicians to consider positive JAK inhibitor safety data.

Benjamin Ungar, MD, shares groundbreaking insights on seborrheic dermatitis and emerging treatments in dermatology at ISDS 2025.

Neuroimmune modulation, including vagus nerve stimulation, is highlighted as a promising strategy for patients unresponsive to biologics.

Kilian Eyerich, MD, PhD, argues that classifying skin diseases by immune response patterns offers clearer therapeutic guidance than traditional morphology.

Catch up on coverage from the final day of the 2025 Elevate-Derm Fall Conference.

At Elevate-Derm, Buchi Neita, PA-C, discussed treatment expectations for vitiligo, triple-combination cream for acne, early diagnosis in HS, and what she’s looking forward to in the 2026 pipeline.

At Elevate-Derm Fall, Patricia Delgado, DNP, AGPCNP, DCNP, PMHNP, outlined practical ways dermatology clinicians can incorporate psychodermatology principles and previewed the upcoming Psych and Skin video series.

Lisa Weiss, MMSc, PA-C, and Justin Love, PA-C, discuss the importance of broad differentials, repeat biopsies, and national networking to strengthen diagnostic accuracy and provider support at Elevate-Derm Fall.

Julio Gonzalez Paoli, MD, shares tips for early lupus diagnosis at the Elevate-Derm Fall Conference.

Catch up on coverage from the third day of the 2025 Elevate-Derm Fall Conference.

At Elevate-Derm Fall, Peter Lio, MD, discussed how flexible clinical reasoning and an expanding therapeutic pipeline, particularly hidradenitis suppurativa and atopic dermatitis, are reshaping patient management heading into 2026.

Diego Ruiz Dasilva, MD, shares his expert insights on vitiligo, including treatment options, future therapies, and the importance of combination therapy for effective management.

Hilary Baldwin, MD, shares tips for diagnosing rosacea in patients with darker skin tones.

At Elevate-Derm Fall, sisters Shanna Miranti, MPAS, PA-C, and Larissa Schmidt, DPM, reviewed the benefits of cross-specialty collaboration for patient care.

Michael Rosenblum’s team identified a previously underappreciated fibroblast subset that actively regulates inflammation, fibrosis, and microbial containment in the skin.

Therapeutic modulation of mitochondria offers a pathway to control multiple cytokine pathways simultaneously.